MarketReportsOnline.com adds "Europe Cancer Biomarker Market Forecast 2019-2027" report to its research store.
Pune, India -- (SBWIRE) -- 02/13/2019 -- The Europe cancer biomarker market is poised to grow at a CAGR of 10.83% for the years 2019-2027. Technological progress in research and developmental activities has progressed the growth of the cancer biomarker market in Europe.
Access complete report available at http://www.marketreportsonline.com/781788.html.
The European market has a huge opportunity to grow in personalized medication on account of the support generated for the biomarkers test, growing medical tourism and the rising number of cancer patients in the region. Also, the various market segments and sub-segments with respect to biomarkers, application, cancer type and profiling technology are proving to be quite profitable for the market growth during the forecast period. However, the lack of acceptance of the cancer biomarker from the general populace, unfavorable compensation and the shortage of skilled personnel are some of the major challenges faced by the market in the region.
Some of the leading players in the market are Agendia N.V., Becton Dickinson and Company, Qiagen N.V., Diadexus Inc. (Acquired By Diazyme Laboratories), Aureon Biosciences, Inc., Agilent Technologies, Inc., Clarient, Inc. (Acquired By Neogenomics Laboratories), Astellas Pharma Inc., Beckman Coulter, Sanofi, Bristol-Myers Squibb, Abbott Laboratories, Roche Diagnostics Ltd., Illumina, Inc. and Celgene Corporation.
Purchase a copy of this research report at http://www.marketreportsonline.com/contacts/purchase.php?name=781788.
About Market Reports Online
Market Reports Online is a comprehensive online library of more than 100,000 reports, in-depth market research studies on thousands of micro markets and a range of industries. The reports are analytically and statistically rich, and offer a comprehensive view of the dynamic market scenario across the globe. We offer online and offline support services to ensure your research requirements are met on time.
Tel: + 1 888 391 5441